Best Ziftomenib (Komzifti) Medicine in India

Ziftomenib (Komzifti) is a targeted anticancer treatment used to treat adults with relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation when there are no satisfactory alternative treatment options. It belongs to a group of medicines called menin inhibitors and works by blocking menin-related signaling involved in abnormal leukemia-cell growth and survival, helping to control the disease.

Ziftomenib (Komzifti) should be taken exactly as prescribed by your doctor. It is taken orally once daily and should be continued as recommended by your healthcare professional. Regular medical check-ups and laboratory tests are required to monitor your blood counts, treatment response, and overall health.

Common side effects of Ziftomenib (Komzifti) may include nausea, vomiting, diarrhea, decreased appetite, fatigue, swelling, muscle or joint pain, and changes in blood cell counts. Ziftomenib may also cause serious conditions such as differentiation syndrome and changes in heart rhythm. Inform your doctor immediately if you develop fever, swelling, shortness of breath, rapid weight gain, dizziness, or other concerning symptoms. Before starting treatment, tell your doctor about your medical history and all medicines, vitamins, and supplements you are taking.

Treatment of NPM1-Mutated Acute Myeloid Leukemia

Ziftomenib (Komzifti) is used to treat adults with relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation when there are no satisfactory alternative treatment options. It works by blocking menin-related signaling involved in abnormal leukemia-cell growth, helping to control the disease.

Some side effects of Ziftomenib (Komzifti) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Ziftomenib (Komzifti)

Take Ziftomenib (Komzifti) exactly as prescribed by your doctor, usually once daily. It can be taken with or without food. Swallow it whole with water and do not crush, chew, or break it. Take each dose at approximately the same time each day and follow your doctor's instructions if you miss a dose or vomit after taking it. Regular blood tests and medical check-ups are required to monitor treatment response and possible side effects.

Ziftomenib (Komzifti) is a menin inhibitor that blocks the interaction between menin and certain leukemia-related proteins. This disrupts abnormal gene signaling involved in the growth and survival of NPM1-mutated leukemia cells, helping to promote leukemia-cell differentiation and reduce their growth.

AlcoholCONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as nausea, fatigue, or dizziness. Follow your doctor's advice.

PregnancyCONSULT YOUR DOCTOR

Komzifti may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment and for the recommended period after the last dose, as the effects on a breastfed child are not fully known.

DrivingCONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience dizziness, fatigue, or other effects that may impair your alertness or coordination.

KidneyCAUTION

Inform your doctor if you have kidney problems. Your doctor may monitor kidney function and provide appropriate medical care during treatment.

LiverCAUTION

Tell your doctor about any liver condition. Regular liver function tests may be recommended, and report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.